TY  - GEN
AU  - Baldus,Claudia D
AU  - Tanner,Stephan M
AU  - Ruppert,Amy S
AU  - Whitman,Susan P
AU  - Archer,Kellie J
AU  - Marcucci,Guido
AU  - Caligiuri,Michael A
AU  - Carroll,Andrew J
AU  - Vardiman,James W
AU  - Powell,Bayard L
AU  - Allen,Steven L
AU  - Moore,Joseph O
AU  - Larson,Richard A
AU  - Kolitz,Jonathan E
AU  - de la Chapelle,Albert
AU  - Bloomfield,Clara D
TI  - BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: a Cancer and Leukemia Group B Study
SN  - 0006-4971
PY  - 2003///1002
KW  - Acute Disease
KW  - Adult
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Cytarabine
KW  - Daunorubicin
KW  - Etoposide
KW  - Female
KW  - Genetic Markers
KW  - Genetic Predisposition to Disease
KW  - epidemiology
KW  - Humans
KW  - Karyotyping
KW  - Leukemia, Myeloid
KW  - Male
KW  - Middle Aged
KW  - Multivariate Analysis
KW  - Neoplasm Proteins
KW  - genetics
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Reverse Transcriptase Polymerase Chain Reaction
KW  - Risk Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1182/blood-2003-02-0359
ER  -